Comparison of cytotoxicity in vitro and irritation in vivo for aqueous and oily solutions of surfactants

References

• Achouri D, Alhanout K, Piccerelle Ph, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–17
   PubMed Web of Science ®Google Scholar
• Jiao J. Polyoxyethylated non-ionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev 2008;60:1663–73
   PubMed Web of Science ®Google Scholar
• Jarvinen K, Jarvinen T, Urtti A. Ocular absorption following topical delivery. Adv Drug Deliv Rev 1995;16:3–19
   Web of Science ®Google Scholar
• Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms. Drug Discov Today 2008;13:606–12
   PubMed Web of Science ®Google Scholar
• Vinardell MP, Mitjans M. Alternative methods for eye and skin irritation tests: an overview. J Pharm Sci 2008;97:46–59
   PubMed Web of Science ®Google Scholar
• Curren RD, Harbell JW. In vitro alternatives for ocular irritation. Environ. Health Perspect 1998;106:1–12
   Google Scholar
• Worth A, Balls M. Alternative (non-animal) methods for chemical testing: current status and future prospects. A report prepared by ECVAM and the ECVAM working group on chemicals. Altern Lab Anim 2002;30:1–125
   PubMed Web of Science ®Google Scholar
• Pape WJ, Hoppe U. In vitro methods for the assessment of primary local effects of topically applied preparations. Skin Pharmacol 1991;4;205–12
   PubMedGoogle Scholar
• Huhtala A, Salminen L, Tähti H, Uusitalo H. Corneal models for the toxicity testing of drugs and drug releasing materials. In: Ashammakhi N, ed. Topics in multifunctional biomaterials and devices. Finland
   Google Scholar
• Maurer JK, Li HF, Petroll WM, et al. Confocal microscopic charactertization of initial corneal changes of surfactant-induced eye irritation in the rabbit. Toxicol Appl Pharmacol 1997;143:291–300
   PubMed Web of Science ®Google Scholar
• Jester JV, Li HF, Petroll WM, et al. Area and depth of surfactant-induced corneal injury correlates with cell death. IOVS 1998;39:922–36
   PubMed Web of Science ®Google Scholar
• Ohno Y, Kaneko T, Inoue T, et al. Interlaboratory validation of the in vitro eye irritation tests for cosmetics ingredients. Overview of the validation study and Draize scores for the evaluation of the tests. Toxicol In Vitro 1999;13:73–98
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR. The Draize eye test. Surv Ophthalmol 2001;45:493–515
   PubMed Web of Science ®Google Scholar
• Prinsen MK. The Draize eye test and in vitro alternatives: a left-handed marriage? Toxicol In Vitro 2006;20:78–81
   PubMed Web of Science ®Google Scholar
• Tamilvanan S, Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm 2004;58:357–68
   PubMed Web of Science ®Google Scholar
• Yang W, Acosta D. Cytotoxicity potential of surfactant mixtures evaluated by primary cultures of rabbit corneal epithelial cells. Toxicol Lett 1994;70:309–18
   PubMed Web of Science ®Google Scholar
• Pouton CW, Porter Ch. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60:625–37
   PubMed Web of Science ®Google Scholar
• Furrer P, Plazonnet B, Mayer JM, Gurny R. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm 2000;207:89–98
   PubMed Web of Science ®Google Scholar
• Kapoor Y, Howell BA, Chauhan A. Liposome assay for evaluating ocular toxicity of surfactants. IOVS 2009;50:2727–35
   PubMed Web of Science ®Google Scholar
• Vian L, Vincent J, Maurin J, et al. Comparison of three in vitro cytotoxicity assays for estimating surfactant ocular irritation. Toxicol In Vitro 1995;9:185–90
   PubMed Web of Science ®Google Scholar
• Gamberlain M, Gad SC, Gautheron P, Prinsen MK. IRAG working group 1. Organotypic models for the assessment/prediction of ocular irritation. Interagency Regulatory Alternatives Group. Food Chem Toxicol 1997;35:23–37
   PubMed Web of Science ®Google Scholar
• Rubinstein L, Paul K, Shoemaker R, et al. Comparison of in vitro anticancer-drug screening data with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J Natl Cancer Inst 1990;82:1113–18
   PubMed Web of Science ®Google Scholar
• Bopp SK, Lettieri T. Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line. BMC Pharmacol 2008;8:1–11
   PubMedGoogle Scholar
• Fiscella RG, Le H, Lam TT, Labib S. Stability of cyclosporine 1% in artificial tears. J Ocul Pharmacol Ther 1996;12:1–4
   PubMed Web of Science ®Google Scholar
• Lallemand F, Furrer P, Felt-Baeyens O, et al. A novel water-soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics. Int J Pharm 2005;295:7–14
   PubMed Web of Science ®Google Scholar